| For: | Oh BY, Lee RA, Kim KH. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer. World J Gastroenterol 2011; 17(20): 2563-2571 [PMID: 21633662 DOI: 10.3748/wjg.v17.i20.2563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i20/2563.htm |
| Number | Citing Articles |
| 1 |
Marco Mazzoletti, Gemma Texidó. Target Identification and Validation in Drug Discovery. Methods in Molecular Biology 2013; 986 doi: 10.1007/978-1-62703-311-4_20
|
| 2 |
Mohammed Faruk, Sani Ibrahim, Surajo Mohammed Aminu, Ahmed Adamu, Adamu Abdullahi, Aishatu Maude Suleiman, Abdulmumini Hassan Rafindadi, Abdullahi Mohammed, Yawale Iliyasu, John Idoko, Rakiya Saidu, Abdullahi Jibril Randawa, Halimatu Sadiya Musa, Atara Ntekim, Khalid Zahir Shah, Sani Abubakar, Kasimu Umar Adoke, Muhammad Manko, Cheh Agustin Awasum, Irina V. Lebedeva. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0245581
|
| 3 |
Feng Wang, Wei He, Peng Fanghui, Liuxing Wang, Qingxia Fan. NF‐κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase‐9 and epithelial‐to‐mesenchymal transition. Cell Biology International 2013; 37(8) doi: 10.1002/cbin.10089
|
| 4 |
Hao Xu, Shangjun Wu, Xin Shen, Zhan Shi, Ding Wu, Yuan Yuan, Wei Jiang, Qianliang Wang, Qin Ke, Qing Mao, Xianlong Li, Yong Liu, Pingcheng Yuan, Qinghan Zhang, Enying Huang, Xiaogang Chen. RETRACTED: Methylation‐mediated miR‐214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN. Journal of Cellular and Molecular Medicine 2020; 24(11) doi: 10.1111/jcmm.15287
|
| 5 |
Ziyad Binkhathlan, Aws Alshamsan. Emerging Nanodelivery Strategies of RNAi Molecules for Colon Cancer Therapy: Preclinical Developments. Therapeutic Delivery 2012; 3(9) doi: 10.4155/tde.12.89
|
| 6 |
Barbara Altieri, Silviu Sbiera, Silvia Della Casa, Isabel Weigand, Vanessa Wild, Sonja Steinhauer, Guido Fadda, Arkadius Kocot, Michaela Bekteshi, Egle M. Mambretti, Andreas Rosenwald, Alfredo Pontecorvi, Martin Fassnacht, Cristina L. Ronchi. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. Oncotarget 2017; 8(6) doi: 10.18632/oncotarget.14067
|
| 7 |
SANG-WON HONG, KYUNG HEE JUNG, MYUNG-JOO CHOI, DA YOUNG KIM, HEE-SEUNG LEE, HONG-MEI ZHENG, GUANG YONG LI, IBRAHIM M. EL-DEEB, BYUNG SUN PARK, SO HA LEE, SOON-SUN HONG. Anticancer effects of KI-10F: A novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer. International Journal of Oncology 2012; 41(5) doi: 10.3892/ijo.2012.1609
|
| 8 |
Darren Finlay, Peter Teriete, Mitchell Vamos, Nicholas D. P. Cosford, Kristiina Vuori. Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. F1000Research 2017; 6 doi: 10.12688/f1000research.10625.1
|
| 9 |
Asiyeh Jebelli, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Lobat Tayebi. Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer. Medicinal Research Reviews 2021; 41(1) doi: 10.1002/med.21735
|
| 10 |
A. Deezagi, S. Ansari-Majd, N. Vaseli-Hagh. Induced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNA. Clinical and Translational Oncology 2012; 14(10) doi: 10.1007/s12094-012-0868-1
|
| 11 |
Gang Li, Hong Chang, Yun-Peng Zhai, Wei Xu. Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2013; 14(9) doi: 10.7314/APJCP.2013.14.9.4943
|
| 12 |
Gemma Texidó. Target Identification and Validation in Drug Discovery. Methods in Molecular Biology 2013; 986 doi: 10.1007/978-1-62703-311-4_18
|
| 13 |
Chao Pan, Yang Wang, Min Zhang, Taotao Zhou, Liqin Ye, Fenqing Tang, Hongyu Liu, Yuzhong Yan, Yong Gan. Akkermansia Muciniphila‐Inspired Oral siRNA Delivery by Active Matrix‐Penetration and Intracellular Endoplasmic Reticulum Accumulation. Advanced Materials 2026; 38(7) doi: 10.1002/adma.202515901
|
| 14 |
Dae-Seong Myung, Young-Lan Park, Cho-Yun Chung, Hyung-Chul Park, Jong-Sun Kim, Sung-Bum Cho, Wan-Sik Lee, Kyung-Hwa Lee, Jae-Hyuk Lee, Young-Eun Joo, DunFa Peng. Expression of Livin in Colorectal Cancer and Its Relationship to Tumor Cell Behavior and Prognosis. PLoS ONE 2013; 8(9) doi: 10.1371/journal.pone.0073262
|
| 15 |
Bo Young Oh, Kwang Ho Kim, Soon Sup Chung, Ryung-Ah Lee. Silencing thelivingene enhances the cytotoxic effects of anticancer drugs on colon cancer cells. Annals of Surgical Treatment and Research 2016; 91(6) doi: 10.4174/astr.2016.91.6.273
|
| 16 |
Jiequn Li, Zhulin Yang, Shengfu Huang, Daiqiang Li. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820971676
|
| 17 |
Wei Xu, Hong Chang, Cheng-Kun Qin, Yun-Peng Zhai. Impact of Co-transfection with Livin and Survivin shRNA Expression Vectors on Biological Behavior of HepG2 Cells. Asian Pacific Journal of Cancer Prevention 2013; 14(9) doi: 10.7314/APJCP.2013.14.9.5467
|
| 18 |
Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, Emmanouil Fokas, Franz Rödel. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions. Cancers 2021; 13(4) doi: 10.3390/cancers13040624
|
| 19 |
Nagindra Prashad. Pheochromocytoma, Paraganglioma and Neuroblastoma. 2021; doi: 10.5772/intechopen.96021
|